ARCHIVED: NOT AVAILABLE FOR CREDIT
Breast Predictive Factor Update

 

American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP) produced collaborative guidelines for HER2 and ER/PgR Testing in Breast Cancer in 2007 and 2011 respectively The HER2 Guideline has recently been updated. This course summarizes the content of these guidelines and updates the recommendations for HER2 included in the 2013 publication.

Originally presented on February 10, 2015, in Salt Lake City, Utah.

Lecture Presenter

Elizabeth H. Hammond, MD, FCAP

Elizabeth H. Hammond, MD, FCAP

Consulting Pathologist
Intermountain Healthcare
Professor of Pathology
University of Utah School of Medicine

Dr. Elizabeth Hammond is a consulting pathologist with Intermountain Healthcare and professor of pathology and adjunct professor of internal medicine (cardiology) at the University of Utah School of Medicine. She is also a past member of Intermountain’s Board of Trustees. She was recently recognized and presented with two awards presented by the College of American Pathologists (CAP): 1) the CAP Pathology Advancement Award, of which she is the first recipient; and 2) the CAP Excellence in Education Award.

Objectives

After this presentation, participants will be able to:

  • Describe key elements of the ASCO/CAP HER2 and ER/PgR guidelines and contrast their features.
  • Identify the changes in the 2013 HER2 update and illustrate the significance of these changes on testing execution.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories